KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Assets Average (2016 - 2025)

Historic Assets Average for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to $1.4 billion.

  • Supernus Pharmaceuticals' Assets Average rose 540.26% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 540.26%. This contributed to the annual value of $1.3 billion for FY2024, which is 1122.2% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Assets Average is $1.4 billion, which was up 540.26% from $1.4 billion recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Assets Average high stood at $1.7 billion for Q1 2023, and its period low was $1.3 billion during Q4 2023.
  • For the 5-year period, Supernus Pharmaceuticals' Assets Average averaged around $1.5 billion, with its median value being $1.5 billion (2021).
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Assets Average soared by 2814.28% in 2021, and later tumbled by 2611.54% in 2024.
  • Supernus Pharmaceuticals' Assets Average (Quarter) stood at $1.6 billion in 2021, then rose by 4.67% to $1.7 billion in 2022, then dropped by 24.53% to $1.3 billion in 2023, then rose by 5.77% to $1.4 billion in 2024, then rose by 3.37% to $1.4 billion in 2025.
  • Its Assets Average was $1.4 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.